Described are methods and devices useful for supporting posterior vaginal tissue for various purposes such as treating or preventing vaginal prolapse or enterocele, especially in a patient not having a uterus, the devices including implants designed to contact the vaginal cuff and connect to sacral anatomy such as the sacrum or the uterosacral ligaments.

In a general aspect, a medical device can include an external arm having a receiving mechanism, and an internal arm coupled to the external arm such that the receiving mechanism of the external arm is movable with respect to the internal arm. The medical device can also include a sliding component including a needle configured to be coupled to a portion of an implant and configured to slidably move the needle toward the receiving mechanism of the external arm.

A medical device is provided including an artificial contractile structure which may be used to assist the functioning of a hollow organ. The medical device includes an artificial contractile structure including at least one contractile element configured to contract an organ, in such way that the contractile element is in a resting or in an activated position, at least one actuator configured to activate the contractile structure, and at least one source of energy to power the actuator. The medical device includes a corrosion reducing system configured to reduce corrosion of the medical device.

In an embodiment, a medical device is a bodily implant and includes an elongate member. The elongate member has an inner edge that defines an opening. At least a portion of the inner edge being treated.

A surgical device is provided. The surgical device includes a housing adapted for mounting on a finger of a user; and at least one guide tube attached along a length of the housing. The guide tube is configured for guiding a tissue repair implant from a proximal opening to a distal opening thereof.

According to an aspect, pelvic implants optionally including the ability to engage a spreader tool for spreading the implant within the patient, also optionally including a frame, exemplary implants being capable of being used to treat pelvic floor disorders, for example by supporting of levator tissue, and methods of surgically placing pelvic implants.

In one embodiment, an apparatus includes a support portion disposable within a pelvic region and a strap extending from the support portion. The strap has a length and is configured to be disposed at least partially within a pelvic tissue. A sleeve is releasably disposed over at least a portion of the strap. The sleeve has a length that is longer than the length of the strap. In some embodiments, the length of the sleeve is at least twice as long as the length of the strap. In some embodiments, a suture couples the sleeve to the strap. The apparatus can also include a suture disposed at least partially within an interior of the sleeve and forming two strands of suture within the interior of the sleeve. The two strands are separated by a distance defined by a separator portion of the sleeve.

Resorbable implants comprising poly(butylene succinate) and copolymers thereof have been developed. The implants are preferably sterilized, and contain less than 20 endotoxin units per device as determined by the limulus amebocyte lysate (LAL) assay, and are particularly suitable for use in procedures where prolonged strength retention is necessary, and can include one or more bioactive agents. The implants may be made from fibers and meshes of poly(butylene succinate) and copolymers thereof, or by 3d printing, and the fibers may be oriented. Coverings and receptacles made from forms of poly(butylene succinate) and copolymers thereof have also been developed for use with cardiac rhythm management devices and other implantable devices. These coverings and receptacles may be used to hold, or partially/fully cover, devices such as pacemakers and neurostimulators. The coverings and receptacles are made from meshes, webs, lattices, non-wovens, films, fibers, and foams, and contain antibiotics such as rifampin and minocycline.

An implantable device for treating a patient suffering from female urinary stress incontinence includes an elongate sling for supporting the urethra, the sling having first and second ends. First and second tabs extend from the first and second ends of the sling, respectively for engaging supportive tissue superior to the portion of the urethra being supported. Each tab has a ratcheted section of alternating relatively projecting and relatively recessed portions for engaging the supportive tissue.

An insertion device includes an elongate member and a stylet. The elongate member has a proximal end portion, a distal end portion, and defines a lumen therethrough. The stylet has a proximal end portion, a distal end portion, and is slidably coupled to the elongate member. The stylet is configured to move from a first position to a second position with respect to the elongate member. The proximal end portion of the stylet is configured to removably couple a mesh carrier thereto. A portion of the proximal end portion of the stylet is disposed outside of the lumen of the elongate member when the stylet is in its first position and is disposed within the lumen when the stylet is in its second position.